Connect with us

Hi, what are you looking for?

Jewish Business News

Science

Research: A Single Dose of ADHD Drug Can Reduce Fall Risk Among Elderly Adults


Old-People-Falling

BGU researchers have discovered that a single dose of methylphenidate (MPH), used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy, helps to improve balance control during walking, hence reducing the risk of falls among elderly adults. Falls in older adults are the leading cause of hip fractures and other injury-related visits to emergency rooms and of accidental death. Age-related deterioration in gait and balance is a major contributor to falls in older adults.

According to a study published in The Journals of Gerontology, the BGU researchers found that a single dose of MPH improves walking by reducing the number of step errors and the step error rate in both single and dual tasks.

“Our results add to a growing body of evidence showing that MPH may have a role as a therapeutic option for improving gait and reducing fall risk in older adults, ” said Itshak Melzer of BGU’s Schwartz Movement Analysis and Rehabilitation Laboratory, Department of Physical Therapy, Faculty of Health Sciences. “This is especially true in real-life situations, where the requirement to walk commonly occurs under more complicated, ‘dual task’ circumstances with cognitive attention focused elsewhere (e.g., watching traffic, talking) and not on performing a specific motor task.”

The study participants were 30 healthy older adults who were at least 70 years-old and had the ability to walk 70 feet (20 meters) without personal assistance or an assistive device. The participants were given a single dose (10 mg.) of MPH and were assessed under four task conditions of single and combined motor and cognitive tasks.
“The enhanced attention that comes about as a result of MPH may lead to improved balance control during walking, especially in dual task conditions, ” Meltzer explains. “Our findings that MPH improves gait can be explained not just by its effect of attentional improvements, but also by indications that it has a direct influence on areas of the brain that deal with motor and balance control.”

The study was supported by a grant from Myers-JDC-Brookdale Institute of Gerontology and Human Development and Eshel-The Association for the Planning and Development of Services for the Aged in Israel.

1 Comment

1 Comment

  1. edwartfruitman

    October 4, 2014 at 9:32 am

    This study relates Alzheimer with ADHD. In Alzheimer patients, falling down gets increase as they keep on aging. If ADHD Drugs reduce the problem of foot-slipping, it means these drugs also work on memory parts of our brain. This is co-relating a learning disorder with a memory loss disease. That’s why the next step for research should be to find common points between learning and memory parts of the brain. http://southshoretms.com/

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

Business

Now Platika joins and elite club of $10 billion plus Israeli firms.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

Advertisement